Primary care for adults on the autism spectrum

Medical Clinics of North America

Volumn 98, Issue 5, 2014, Pages 1169-1191

  Nicolaidis, Christina ^a,b,d   Kripke, Clarissa Calliope ^c   Raymaker, Dora ^a,d  

^a PORTLAND STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Academic Autism Spectrum Partnership in Research and Education   (United States)

Author keywords

Adults; Autism spectrum disorders; Developmental disabilities; Primary care

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; RISPERIDONE;

ABUSE; ACCOMMODATION; ADULT; ANXIETY; ASSISTIVE TECHNOLOGY; AUTISM; BEHAVIOR CHANGE; CAREGIVER SUPPORT; DAILY LIFE ACTIVITY; EPILEPSY; ETHICAL DECISION MAKING; FEEDING; GASTROINTESTINAL DISEASE; HEALTH CARE; HEALTH CARE ACCESS; HUMAN; LEGAL ASPECT; METABOLIC SYNDROME X; MORTALITY; NUTRITIONAL DISORDER; PATIENT DECISION MAKING; PATIENT REFERRAL; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSORY STIMULATION; SLEEP DISORDER; VIOLENCE;

ADULTS; AUTISM SPECTRUM DISORDERS; DEVELOPMENTAL DISABILITIES; PRIMARY CARE;

ADULT; ANTIPSYCHOTIC AGENTS; BEHAVIOR; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITIVE THERAPY; COMMUNICATION AIDS FOR DISABLED; CRIME VICTIMS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EATING DISORDERS; EPILEPSY; GASTROINTESTINAL DISEASES; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; LIFE EXPECTANCY; MENTAL COMPETENCY; MENTAL DISORDERS; METABOLIC SYNDROME X; NUTRITION DISORDERS; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; PROXY; REFERRAL AND CONSULTATION; SLEEP DISORDERS; VIOLENCE;

EID: 84905970873     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2014.06.011     Document Type: Review

References (62)

1. Brugha T.S., McManus S., Bankart J., et al. Epidemiology of autism spectrum disorders in adults in the community in England. Archives of general psychiatry 2011, 68(5):459-465.
2. Nicolaidis C., Raymaker D., McDonald K., et al. Collaboration Strategies in Nontraditional Community-Based Participatory Research Partnerships: lessons from an academic-community partnership with autistic self-advocates. Prog Community Health Partnersh 2011, 5(2):143.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5) 2013, American Psychiatric Association, Washington, DC.
4. Markram K., Markram H. The intense world theory-a unifying theory of the neurobiology of autism. Front Hum Neurosci 2010, 4:224.
5. Nicolaidis C. What can physicians learn from the neurodiversity movement?. Virtual Mentor 2012, 14(6):503.
6. Rogers K., Dziobek I., Hassenstab J., et al. Who cares? Revisiting empathy in Asperger syndrome. JAutism Dev Disord 2007, 37(4):709-715.
7. Lord C., Rutter M., DiLavore P., et al. Autism diagnostic observation schedule: ADOS-2 2012, Western Psychological Services, Torrance (CA).
8. White S.W., Oswald D., Ollendick T., et al. Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev 2009, 29(3):216-229.
9. Stewart M.E., Barnard L., Pearson J., et al. Presentation of depression in autism and Asperger syndrome. A review. Autism 2006, 10(1):103-116.
10. Doshi-Velez F., Ge Y., Kohane I. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics 2014, 133(1):e54-e63.
11. Tyler C.V., Schramm S.C., Karafa M., et al. Chronic disease risks in young adults with autism spectrum disorder: forewarned is forearmed. Am J Intellect Dev Disabil 2011, 116(5):371-380.
12. Kohane I.S., McMurry A., Weber G., et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 2012, 7(4):e33224.
13. Hughes R.B., Lund E.M., Gabrielli J., et al. Prevalence of interpersonal violence against community-living adults with disabilities: a literature review. Rehabil Psychol 2011, 56(4):302.
14. Woolfenden S., Sarkozy V., Ridley G., et al. Asystematic review of two outcomes in autism spectrum disorder-epilepsy and mortality. Dev Med Child Neurol 2012, 54(4):306-312.
15. Shavelle R.M., Strauss D. Comparative mortality of persons with autism in California, 1989-1996. JInsur Med 1998, 30(4):220-225.
16. Shavelle R.M., Strauss D.J., Pickett J. Causes of death in autism. JAutism Dev Disord 2001, 31(6):569-576.
17. Perkins E.A., Berkman K.A. Into the unknown: aging with autism spectrum disorders. Am J Intellect Dev Disabil 2012, 117(6):478-496.
18. Viscidi E.W., Triche E.W., Pescosolido M.F., et al. Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS One 2013, 8(7):e67797.
19. Chapman M., Iddon P., Atkinson K., et al. The misdiagnosis of epilepsy in people with intellectual disabilities: a systematic review. Seizure 2011, 20(2):101-106.
20. Kerr M., Scheepers M., Arvio M., et al. Consensus guidelines into the management of epilepsy in adults with an intellectual disability. JIntellect Disabil Res 2009, 53(8):687-694.
21. Srikanth R., Cassidy G., Joiner C., et al. Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities. JIntellect Disabil Res 2011, 55(1):53-62.
22. Charlot L., Abend S., Ravin P., et al. Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities. JIntellect Disabil Res 2011, 55(2):199-209.
23. Buie T., Campbell D.B., Fuchs G.J., et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010, 125(Suppl 1):S1-S18.
24. Humphries K., Traci M.A., Seekins T. Nutrition and adults with intellectual or developmental disabilities: systematic literature review results. Intellect Dev Disabil 2009, 47(3):163-185.
25. Davis T.E., Hess J.A., Moree B.N., et al. Anxiety symptoms across the lifespan in people diagnosed with autistic disorder. Res Autism Spectr Disord 2011, 5(1):112-118.
26. Allen D., Langthorne P., Tonge B., et al. Towards the prevention of behavioural and psychiatric disorders in people with intellectual disabilities. JAppl Res Intellect Disabil 2013, 26(6):501-514.
27. Rose N., Rose J., Kent S. Staff training in intellectual disability services: a review of the literature and implications for mental health services provided to individuals with intellectual disability. Int J Dev Disabil 2012, 58(1):24-39.
28. Lunsky Y., Lin E., Balogh R., et al. Are adults with developmental disabilities more likely to visit EDs?. Am J Emerg Med 2011, 29(4):463-465.
29. Fletcher R., Loschen E., Stavrakaki C., et al. DM-ID: diagnostic manual-intellectual disability: a textbook of diagnosis of mental disorders in persons with intellectual disability 2007, NADD Press, Kingston (NY).
30. Polimeni M., Richdale A., Francis A. Asurvey of sleep problems in autism, Asperger's disorder and typically developing children. JIntellect Disabil Res 2005, 49(4):260-268.
31. Matson J.L., Ancona M.N., Wilkins J. Sleep disturbances in adults with autism spectrum disorders and severe intellectual impairments. JMent Health Res Intellect Disabil 2008, 1(3):129-139.
32. Sivertsen B., Posserud M.B., Gillberg C., et al. Sleep problems in children with autism spectrum problems: a longitudinal population-based study. Autism 2012, 16(2):139-150.
33. van de Wouw E., Evenhuis H., Echteld M. Prevalence, associated factors and treatment of sleep problems in adults with intellectual disability: a systematic review. Res Dev Disabil 2012, 33(4):1310-1332.
34. Rossignol D.A., Frye R.E. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011, 53(9):783-792.
35. Hollway J.A., Aman M.G. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil 2011, 32(3):939-962.
36. Hylkema T., Vlaskamp C. Significant improvement in sleep in people with intellectual disabilities living in residential settings by non-pharmaceutical interventions. JIntellect Disabil Res 2009, 53(8):695-703.
37. Krahn G.L., Hammond L., Turner A. Acascade of disparities: health and health care access for people with intellectual disabilities. Ment Retard Dev Disabil Res Rev 2006, 12(1):70-82.
38. Iezzoni L.I., O'Day B.L., Killeen M., et al. Communicating about health care: observations from persons who are deaf or hard of hearing. Ann Intern Med 2004, 140(5):356-362.
39. Iezzoni L.I., Davis R.B., Soukup J., et al. Satisfaction with quality and access to health care among people with disabling conditions. Int J Qual Health Care 2002, 14(5):369-381.
40. Nicolaidis C., Raymaker D., Dern S., et al. Comparison of healthcare experiences in autistic and non-autistic adults: a cross-sectional online survey facilitated byan academic-community partnership. JGen Intern Med 2012, 28(6):761-769.
41. Stewart M.A. Effective physician-patient communication and health outcomes: a review. CMAJ 1995, 152(9):1423-1433.
42. Joseph R.M., Tager-Flusberg H., Lord C. Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. JChild Psychol Psychiatry 2002, 43(6):807-821.
43. Mayes S.D., Calhoun S.L. WISC-IV and WIAT-II profiles in children with high-functioning autism. JAutism Dev Disord 2008, 38(3):428-439.
44. Nicolaidis C, Raymaker D, McDonald K, etal. "Respect the way I need to communicate with you": healthcare experiences of adults on the autistic spectrum. Paper presented at: Annual Meeting of the Society of General Internal Medicine. Phoenix, May 4-7, 2011.
45. Rada R.E. Treatment needs and adverse events related to dental treatment under general anesthesia for individuals with autism. Intellect Dev Disabil 2013, 51(4):246-252.
46. Siegel M., Beaulieu A.A. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice. JAutism Dev Disord 2012, 42(8):1592-1605.
47. Spencer D., Marshall J., Post B., et al. Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics 2013, 132(5):833-840.
48. Dove D., Warren Z., McPheeters M.L., et al. Medications for adolescents and young adults with autism spectrum disorders: a systematic review. Pediatrics 2012, 130(4):717-726.
49. Ching H., Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012, (5). CD009043.
50. Hellings J.A., Cardona A.M., Schroeder S.R. Long-term safety and adverse events of risperidone in children, adolescents, and adults with pervasive developmental disorders. JMent Health Res Intellect Disabil 2010, 3(3):132-144.
51. Frighi V., Stephenson M.T., Morovat A., et al. Safety of antipsychotics in people with intellectual disability. Br J Psychiatry 2011, 199(4):289-295.
52. de Kuijper G., Mulder H., Evenhuis H., et al. Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics. Res Dev Disabil 2013, 34(9):2799-2809.
53. Bobo W.V., Cooper W.O., Stein C.M., et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry 2013, 70(10):1067-1075.
54. Kuijper G., Evenhuis H., Minderaa R., et al. Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. JIntellect Disabil Res 2014, 58(1):71-83.
55. Cooper S.A., Smiley E., Jackson A., et al. Adults with intellectual disabilities: prevalence, incidence and remission of aggressive behaviour and related factors. JIntellect Disabil Res 2009, 53(3):217-232.
56. Hwang Y.S., Kearney P. Asystematic review of mindfulness intervention for individuals with developmental disabilities: long-term practice and long lasting effects. Res Dev Disabil 2013, 34(1):314-326.
57. Harper S.K., Webb T.L., Rayner K. The effectiveness of mindfulness-based interventions for supporting people with intellectual disabilities: a narrative review. Behav Modif 2013, 37(3):431-453.
58. Spek A.A., van Ham N.C., Nyklicek I. Mindfulness-based therapy in adults with an autism spectrum disorder: a randomized controlled trial. Res Dev Disabil 2012, 34:246-253.
59. Lang R., Regester A., Lauderdale S., et al. Treatment of anxiety in autism spectrum disorders using cognitive behaviour therapy: a systematic review. Dev Neurorehabil 2010, 13(1):53-63.
60. Lang R., Koegel L.K., Ashbaugh K., et al. Physical exercise and individuals with autism spectrum disorders: a systematic review. Res Autism Spectr Disord 2010, 4(4):565-576.
61. Lang R., Rispoli M., Machalicek W., et al. Treatment of elopement in individuals with developmental disabilities: a systematic review. Res Dev Disabil 2009, 30(4):670-681.
62. Walker V.L., Snell M.E. Effects of augmentative and alternative communication on challenging behavior: a meta-analysis. Augment Altern Commun 2013, 29(2):117-131.